View Older Stories View More Recent Stories

Jun 23, 2017 04:32PM KBL Merger Corp. IV Announces Closing of Underwriters' Over-Allotment Option in Full in Connection with its Initial Public Offering and Separate Trading of its Common Stock, Rights and Warrants, Comme
Jun 23, 2017 04:25PM Constellation Alpha Capital Corp. Completes Initial Public Offering
Jun 22, 2017 09:09AM Spring Bank Pharmaceuticals (SBPH) Prices 2.88M Common Stock Offering at $13/Share
Jun 22, 2017 09:00AM Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
Jun 21, 2017 05:45AM AveXis (AVXS) Prices 3.75M Shares Offering; Net Proceeds Expected to be Roughly $234.5M
Jun 20, 2017 09:15PM AveXis Announces Pricing of Public Offering of Common Stock
Jun 20, 2017 06:14AM Constellation Alpha Capital Corp. (CNACU) Prices 12.5M Share IPO at $10/Sh
Jun 20, 2017 06:10AM Teladoc (TDOC) PT Raised to $41 at Chardan Capital Markets; Bullish on Best Doctors Deal
Jun 19, 2017 10:48PM Bison Capital Acquisition Corp. Announces Pricing of $52.5 Million Initial Public Offering
Jun 19, 2017 06:57PM Constellation Alpha Capital Corp. Announces Pricing of $125 Million Initial Public Offering
Jun 19, 2017 04:00PM AveXis (AVXS) Plans $200M Common Stock Offering
Jun 19, 2017 04:00PM AveXis Announces Proposed Public Offering of Common Stock
Jun 19, 2017 08:02AM Chardan Capital Markets Upgrades Clovis Oncology (CLVS) to Neutral
Jun 13, 2017 06:32AM Regulus Therapeutics (RGLS): Cutting PT By 50% - Chardan
Jun 13, 2017 02:45AM Kiadis Pharma Raises €5 Million in Private Placement with Institutional Investors
Jun 12, 2017 02:18AM Chardan Capital Markets Starts Catalyst Biosciences (CBIO) at Buy
Jun 9, 2017 07:37AM Microbot Medical (MBOT) Announces Closing of 3.75M Registered Direct Common Offering
Jun 9, 2017 07:30AM Microbot Medical Announces Closing of $10 Million Registered Direct Offering of Common Stock
Jun 7, 2017 04:01PM KBL Merger Corp. IV Completes $100 Million Initial Public Offering
Jun 7, 2017 06:04AM HealthEquity, Inc (HQY) PT Raised to $57 at Chardan Capital Markets; 'Strong Execution'
Jun 6, 2017 04:33AM Chardan Capital Markets Starts Castlight Health Inc. (CSLT) at Buy
Jun 5, 2017 12:30PM Comhear, Inc. Closes $12M Series A Financing; Expands Executive Management Team and Board of Directors
Jun 5, 2017 09:07AM Microbot Medical (MBOT) Announces $10M Direct Offering of Common Stock
Jun 5, 2017 09:05AM Microbot Medical Announces $10 Million Registered Direct Offering of Common Stock
Jun 2, 2017 09:23AM Pre-Open Movers 06/02: (LULU) (SGYP) (AVGO) Higher; (RH) (BOOT) (SVRA) Lower (more...)
Jun 2, 2017 05:50AM Chardan Capital Markets Starts Biocept (BIOC) at Buy, "Pure Play Liquid Biopsy Story"
Jun 1, 2017 08:21PM KBL Merger Corp. IV Announces Pricing of $100 Million Initial Public Offering
May 31, 2017 11:39AM Amicus Therapeutics (FOLD): Priority Review Voucher Is A $125 Million Call Option - Chardan
May 31, 2017 04:55AM Chardan Capital Markets Upgrades Akari Therapeutics (AKTX) to Neutral
May 30, 2017 05:01AM Chardan Capital Markets Starts Assembly Biosciences (ASMB) at Buy, "Sensitivity analyses suggest considerable upside"
May 24, 2017 07:30AM Spring Bank Pharmaceuticals (SBPH) PT More than Doubled to $34 at Chardan Capital Markets
May 22, 2017 04:30PM Castlight Health to Participate in Upcoming Investor Conferences
May 19, 2017 06:06AM Chardan Capital Markets Starts Model N, Inc. (MODN) at Buy; Undervalued Versus Peers
May 17, 2017 09:38AM Smith Micro (SMSI) Announces $2.2M Registered Direct Offering of Common Stock
May 17, 2017 09:38AM Smith Micro Announces $2.2 Million Registered Direct Offering of Common Stock
May 15, 2017 09:37AM Alnylam Pharmaceuticals (ALNY) PT Raised to $110 at Chardan Capital Markets
May 11, 2017 07:11AM Chardan Capital Markets Downgrades CaesarStone Sdot-Yam (CSTE) to Neutral on Valuation
May 10, 2017 05:27PM Astrotech (ASTC) Subsidiary to Pursue Strategic Alternatives
May 10, 2017 05:24PM Astrotech Subsidiary 1st Detect to Pursue Strategic Alternatives
May 5, 2017 10:07AM Alnylam Pharmaceuticals (ALNY) PT Trimmed to $95 at Chardan Capital Markets
May 4, 2017 09:34AM Lion Biotechnologies (LBIO) PT Raised to $20 at Chardan Capital Markets, "Leader In Precision Immuno-Oncology"
May 1, 2017 04:27PM Chardan Capital Markets Starts Spring Bank Pharmaceuticals (SBPH) at Buy; Can Lead in HBV
Apr 28, 2017 04:00PM Forum Merger Corporation Class A Common Stock, Warrants and Rights to Commence Trading Separately on May 2, 2017
Apr 26, 2017 04:01PM REGENXBIO Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
Apr 24, 2017 12:01PM Chardan Capital Markets Reiterates Sell Rating and $6.50 PT on Akari Therapeutcis (AKTX); 'Weak Efficacy for Coversin in the Ph2 PNH COBALT Trial'
Apr 21, 2017 09:42AM SRAX Announces Offering of $3.72 Million of Secured Convertible Debentures
Apr 17, 2017 05:55AM Akari Therapeutics (AKTX) PT Raised to $6.50 at Chardan Capital Markets; 'Skepticism on Coversin in PNH'
Apr 12, 2017 04:34PM Forum Merger Corporation Completes $150,000,000 Initial Public Offering
Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 12, 2017 06:29AM Lion Biotechnologies (LBIO): Reiterating Buy - Chardan
View More Recent Stories View Older Stories